MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
CRGX CARGO Therapeutics
- 14.900
- +1.390+10.29%
Close Dec 20 16:00 ET
- 14.770
- -0.130-0.87%
Post 20:01 ET
685.81MMarket Cap-4.45P/E (TTM)
15.010High12.718Low1.03MVolume13.340Open13.510Pre Close15.23MTurnover3.33%Turnover Ratio6.26P/E (Static)46.03MShares33.92052wk High1.71P/B461.99MFloat Cap12.17052wk Low--Dividend TTM31.01MShs Float33.920Historical High--Div YieldTTM16.97%Amplitude12.170Historical Low14.737Avg Price1Lot Size
About CARGO Therapeutics Company
Cargo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cell therapies for cancer patients. It is involved in evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma whose disease relapsed or was refractory to CD19 CAR T-cell therapy. The company was founded by Crystal Mackall, Nancy Goodman, Louai Labanieh, and Robbie Majzner in December 2019 and is headquartered in San Carlos, CA.
Company Profile
SymbolCRGX
Company NameCARGO Therapeutics
Listing DateNov 10, 2023
Issue Price15.00
Founded2019
CEOMs. Gina Chapman
MarketNASDAQ
Employees116
Fiscal Year Ends12-31
Address835 Industrial Road,Suite 400
CitySan Carlos
ProvinceCalifornia
CountryUnited States of America
Zip Code94070
Phone1-650-449-8950
Websitehttp://cargo-tx.com
Company Executives
- Name
- Position
- Salary
- Gina Chapman
- President, Chief Executive Officer and Director
- 4.99M
- Anup Radhakrishnan
- Chief Financial Officer and Principal Accounting Officer
- 2.51M
- Dr. Shishir Gadam, PhD
- Chief Technical Officer
- --
- Dr. Ginna G. Laport, M.D.
- Chief Medical Officer
- 2.31M
- John A. Orwin, M.B.A.
- Chairman of the Board
- 818.60K
- Jane Pritchett Henderson
- Director
- --
- Abraham Bassan
- Director
- 306.39K
- Dr. Kapil Dhingra, M.B.B.S.
- Director
- --
- David Charles Lubner, C.P.A.,M.S.
- Independent Director
- 514.13K
- Dr. Reid M. Huber, PhD
- Independent Director
- 303.97K
- Dr. Krishnan Viswanadhan
- Independent Director
- 441.51K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
